白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

未开盘 09-03 16:08:21

13.380

-0.003

-0.02%

最高13.540	最低13.380	成交量125.72万
今开13.530	昨收13.383	日振幅1.20%
总市值217.56亿	流通市值29.42亿	总股本16.26亿
成交额1,691万	换手率0.57%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":13.38,"timestamp":1788422901000,"preClose":13.383,"halted":0,"volume":1257225,"delay":0,"changeRate":-0.00022416498542915172,"floatShares":219900000,"shares":1626000000,"eps":2.1413272626066235,"marketStatus":"未开盘","change":-0.003,"latestTime":"09-03 16:08:21","open":13.53,"high":13.54,"low":13.38,"amount":16914088,"amplitude":0.011955,"askPrice":13.39,"askSize":196000,"bidPrice":13.38,"bidSize":54000,"shortable":3,"etf":0,"ttmEps":1.8393499403380584,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":0,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":13.383,"dividendRate":0.038565,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":0.751836,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":20.19,"timestamp":1788418800000,"preClose":20.13,"halted":0,"volume":5148500,"delay":0,"premium":"-43.21"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2664083968","title":"白云山：2026年半年度权益分派实施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083968","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664083968?lang=zh_cn&edition=full","pubTime":"2026-09-03 21:32","pubTimestamp":1788442320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月3日，白云山发布2026年半年度权益分派实施公告称，本次利润分配以方案实施前的公司总股本1，625，790，949股为基数，每股派发现金红利0.30元（含税），共计派发现金红利487，737，284.70元（含税）。股权登记日为2026年9月9日，除权（息）日为2026年9月10日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","600332","BK0196","BK0188","BK0097","00874","BK0096","BK0070","BK0012","BK0028","BK0239","BK1521","BK1197","BK1191","BK1606","BK0175","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875081","title":"白云山：每股派0.30元，股权登记日为9月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875081","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664875081?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:15","pubTimestamp":1788430500,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电，白云山发布2026年半年度权益分派实施公告，每股派0.30元（含税），股权登记日为9月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864171782.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864171782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","600332","00874","BK0096","BK0097","BK0175","BK1606","BK0188","BK1197","BK0012","BK0028","BK0183","BK1515","BK1191","BK0239","BK0070","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664636948","title":"股市必读：白云山新发布《H股公告（证券变动月报表）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664636948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664636948?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:31","pubTimestamp":1788283869,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，白云山报收于20.27元，下跌0.73%，换手率0.71%，成交量10.01万手，成交额2.03亿元。当日关注点交易信息汇总：9月1日主力资金净流入1054.51万元，游资资金净流入1145.35万元，散户资金净流出2199.86万元。公司公告汇总：白云山提交截至2026年8月31日的H股证券变动月报表，H股与A股已发行股份本月均无变动，H股结存219,900,000股，A股结存1,405,890,949股，库存股为零，公众持股量符合香港联交所要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0012","BK0196","BK1521","BK0175","BK0070","BK1197","BK0239","00874","BK1515","BK0096","BK1191","BK0097","BK0188","600332","BK1606","BK0028","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857867","title":"白云山（600332）披露截至8月31日证券变动月报表，9月1日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857867","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857867?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:30","pubTimestamp":1788273038,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，白云山报收于20.27元，较前一交易日下跌0.73%，最新总市值为329.55亿元。该股当日开盘20.28元，最高20.35元，最低20.2元，成交额达2.03亿元，换手率为0.71%。近日，广州白云山医药集团股份有限公司披露截至2026年8月31日的证券变动月报表。公告显示，公司H股和A股的法定注册资本及已发行股份在本月无变动。A股于上交所上市，证券代码600332，上月底及本月底结存均为1,405,890,949股，每股面值人民币1元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0097","BK0028","BK0012","BK0188","600332","161027","BK0196","BK1197","BK0239","BK1521","BK0175","00874","BK1191","BK0183","BK0096","BK1606","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181738952","title":"白云山8月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1181738952","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181738952?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:38","pubTimestamp":1788251890,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司于2026年9月1日发布截至2026年8月31日的股份变动月报表，披露公司当月股本及股份相关情况。公告显示，截至2026年8月31日，H股已发行股份数为219,900,000股，与上月保持一致；A股已发行股份数为1,405,890,949股，较上月底无变动。公司本月底法定/注册股本总额为人民币1,625,790,949元，股本结构整体稳定。报告期内，未出现新增发行、回购、注销或库藏股变动，也无股份期权或股权激励计划的相关变动。本次公告由公司秘书黄雪贞签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028039","title":"股市必读：白云山新发布《北京市中伦（广州）律师事务所关于广州白云山医药集团股份有限公司2026年第一次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663028039?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:22","pubTimestamp":1788135736,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司2026年第一次临时股东会决议公告广州白云山医药集团股份有限公司于2026年8月28日召开2026年第一次临时股东会，会议由董事长陈杰辉主持，采用现场与网络投票相结合方式召开，表决程序符合相关法律法规及公司章程规定。北京市中伦（广州）律师事务所对本次会议进行了见证并出具法律意见书，认为本次股东会决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0070","BK1521","BK0188","BK0239","BK1606","BK0183","BK0175","BK1515","600332","09939","BK0196","BK1197","BK1574","BK0097","BK0096","BK0012","BK1161","159938","00874","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663090188","title":"白云山：8月25日接受机构调研，招商基金、国联民生等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2663090188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663090188?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:33","pubTimestamp":1787934800,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日白云山发布公告称公司于2026年8月25日接受机构调研，招商基金、国联民生、博裕资本、广发证券、东方财富证券、中金公司、华泰证券、中信证券、浙商证券、中信建投参与。该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为29.92。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900001619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0239","BK1147","BK0070","BK0097","600332","BK1515","BK1606","01456","BK0028","BK0096","00874","BK0188","BK0196","BK1521","BK1564","601456","BK0183","BK0175","BK0012","BK1197","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709971","title":"白云山（600332）披露2026年第一次临时股东会法律意见书，8月28日股价下跌0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709971?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:23","pubTimestamp":1787927033,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，白云山报收于20.42元，较前一交易日下跌0.2%，最新总市值为331.99亿元。该股当日开盘20.4元，最高20.45元，最低20.27元，成交额达1.01亿元，换手率为0.35%。近日，白云山发布北京市中伦（广州）律师事务所出具的《关于广州白云山医药集团股份有限公司2026年第一次临时股东会的法律意见书》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK1515","BK1197","BK0188","BK1606","BK0097","BK0239","BK0070","00874","BK0175","BK0096","BK0028","BK1191","BK0183","BK1521","600332","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123557780","title":"白云山（00874）披露2026年首场临时股东会结果　两项普通决议均获逾99%赞成","url":"https://stock-news.laohu8.com/highlight/detail?id=1123557780","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123557780?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:11","pubTimestamp":1787915507,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司8月31日公告披露，其2026年第一次临时股东大会已于2026年8月28日在广州市荔湾区沙面北街45号公司会议室举行。截至2026年8月24日的股权登记日，公司已发行股份总数为1,625,790,949股，其中A股1,405,890,949股，占比约86.47%；H股219,900,000股，占比约13.53%。本次股东大会共有1,382名股东出席或通过网络投票参与，其中A股股东1,381名、H股股东1名；合计代表表决权股份878,869,826股，占公司已发行股份总数的54.057985%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165393969","title":"白云山（00874.HK）披露合并计价出售应收账款交易  总价款25.14亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165393969","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165393969?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:52","pubTimestamp":1787907177,"startTime":"0","endTime":"0","summary":"8月28日，广州白云山医药集团股份有限公司公告，其控股子公司广州医药有限公司与兴证证券资产管理有限公司签署《新增基础资产交割确认函》，向兴证资管出售账面值为1.49亿元应收账款，对价1.46亿元。折价率由双方参照资产支持证券票面利率及存续期限、应收账款未来回收期限及可回收性、专项计划相关税费等因素协商确定。加上本次交易，广州医药在上述期间共向兴证资管出售账面值25.43亿元应收账款，累计取得对价25.14亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188426084","title":"白云山医药：向兴业证券资产管理处置广药集团首批新增基础资产 涉资1.463亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1188426084","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188426084?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:49","pubTimestamp":1787906985,"startTime":"0","endTime":"0","summary":"白云山医药宣布，已向兴业证券资产管理公司完成对广药集团首批新增基础资产的处置工作，交易金额达1.463亿元人民币。\n此次处置涉及广药集团旗下部分新增基础资产，白云山医药选择将其转让给兴业证券资产管理，以实现资产结构的优化调整。\n具体交易细节方面，白云山医药并未在公告中详细披露更多信息，仅确认了交易对手方及交易金额。市场分析人士认为，此举可能是公司资产配置策略的一部分，旨在提升资产运营效率。\n截至发稿时，白云山医药股价未出现明显波动，市场对此消息反应平稳。投资者将继续关注公司后续资产处置进展及相关公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0012","BK0196","BK1521","BK0175","BK0070","BK1197","BK0239","00874","BK1515","BK0096","BK1191","BK0097","BK0188","600332","BK1606","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744773","title":"金戈失守，王老吉失速：白云山420亿元营收为何只赚回20亿元？","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744773","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662744773?lang=zh_cn&edition=full","pubTime":"2026-08-27 14:04","pubTimestamp":1787810690,"startTime":"0","endTime":"0","summary":"近日，白云山（600332.SH，00874.HK）披露了2026年半年度报告。报告期内，公司实现营业收入420.91亿元，同比增长0.61%，自2021年以来已连续六年实现上半年营收同比增长。但光鲜的“六连增”背后，归母净利润却从上年同期的25.16亿元大幅缩水至20.96亿元，同比下滑16.70%；扣非净利润19.39亿元，同比下降12.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608273856251152.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608273856251152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600332","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766998","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766998","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662766998?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:24","pubTimestamp":1787707460,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司重酒石酸去甲肾上腺素注射液通过仿制药一致性评价，该药品2025年国内销售额为76,858万元。公司公告汇总广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评价的公告广州白云山医药集团股份有限公司全资子公司广州白云山明兴制药有限公司收到国家药品监督管理局签发的《药品补充申请批准通知书》，其重酒石酸去甲肾上腺素注射液已通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600016368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK1521","BK1574","BK0183","BK1197","159938","BK1161","09939","BK1515","BK0196","BK0097","BK0070","BK1606","600332","00874","BK0188","BK0096","BK0028","BK0012","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662785910","title":"白云山上半年营收421亿元 净利润同比下降16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662785910","media":"中国经营报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662785910?lang=zh_cn&edition=full","pubTime":"2026-08-25 12:51","pubTimestamp":1787633494,"startTime":"0","endTime":"0","summary":"近日，白云山（600332.SH）披露2026年半年报。报告期内，白云山营收约421亿元，同比增长0.61%，净利润约20.96亿元，同比下降16.7%，扣非净利润约19.4亿元，同比下降12.1%，经营活动产生的现金流净额约-2.7亿元，同比增长92.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608253852593231.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608253852593231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205365","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205365","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662205365?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:18","pubTimestamp":1787599090,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司明兴制药的重酒石酸去甲肾上腺素注射液通过仿制药一致性评价，该药品2025年国内销售额为76,858万元。公司公告汇总广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评价的公告广州白云山医药集团股份有限公司全资子公司广州白云山明兴制药有限公司收到国家药品监督管理局签发的《药品补充申请批准通知书》，其重酒石酸去甲肾上腺素注射液已通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","09939","BK0175","BK0070","BK0096","BK0239","BK1191","BK1521","BK1161","00874","BK0012","BK0028","BK1574","BK0188","159938","BK0196","BK0183","BK1197","BK1515","600332","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220624","title":"白云山（600332）披露2026年半年报摘要，8月24日股价下跌3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220624","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220624?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:12","pubTimestamp":1787566336,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，白云山报收于20.11元，较前一交易日下跌3.83%，最新总市值为326.95亿元。该股当日开盘20.28元，最高20.29元，最低19.89元，成交额达3.44亿元，换手率为1.22%。近日，广州白云山医药集团股份有限公司发布2026年半年度报告摘要。公告显示，报告期内公司实现营业收入420.91亿元，同比增长0.61%；归属于母公司股东的净利润20.96亿元，同比下降16.70%。董事会审议通过利润分配预案，全体董事出席会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400025805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0183","BK0097","BK0188","600332","BK0070","BK0175","00874","BK0096","BK0196","BK0012","BK0239","BK0028","BK1515","BK1191","BK1197","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220522","title":"白云山上半年利润承压，王老吉进军电解质饮料能否打开新局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220522","media":"南方都市报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220522?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:56","pubTimestamp":1787565375,"startTime":"0","endTime":"0","summary":"8月21日，广药集团旗下白云山发布2026年半年度报告。上半年实现营业收入420.91亿元，同比微增0.61%；实现归母净利润20.96亿元，同比大幅下滑16.70%。这份增收不增利的成绩单背后，是现代中药（-11.06%）、天然饮品/王老吉（-12.40%）、化药科技（-15.91%）三大高毛利板块均有所下滑，唯一起量的是低毛利的医药商业（+6.03%），却难以拉动利润。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608243851247292.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608243851247292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0175","BK0012","BK0196","BK0183","00874","BK1191","BK1521","BK0188","BK0097","BK0096","BK1197","BK0028","BK1515","600332","BK0070","BK0239","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661322481","title":"白云山：子公司重酒石酸去甲肾上腺素注射液通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2661322481","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661322481?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:23","pubTimestamp":1787559780,"startTime":"0","endTime":"0","summary":"8月24日，白云山（600332/00874）发布公告，全资子公司广州白云山明兴制药有限公司重酒石酸去甲肾上腺素注射液（1ml:2mg）已通过仿制药质量和疗效一致性评价。重酒石酸去甲肾上腺素注射液用于某些急性低血压状态的血压控制。2026年中期，白云山实现收入420.91亿元，归母净利润20.96亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608243851127226.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608243851127226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0097","BK0070","BK0175","BK1191","BK1521","BK0188","BK1515","BK0239","BK1606","600332","00874","BK0028","BK0096","BK0183","BK0012","BK0196","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258225","title":"港股异动 | 白云山(00874)绩后跌近6% 研发费用显著增加 上半年纯利同比下滑16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258225","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661258225?lang=zh_cn&edition=full","pubTime":"2026-08-24 14:45","pubTimestamp":1787553908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，白云山绩后跌近6%，截至发稿，跌5.64%，报14.22港元，成交额6162.66万港元。消息面上，白云山公布中期业绩，营业收入420.91亿人民币，同比微增0.6%；归属股东净利润20.96亿元，同比下滑16.7%。财报显示，在研发方面，白云山聚焦恶性肿瘤、慢病管理、大呼吸、免疫系统、男科用药五大优势领域，布局在研项目160多项，其中在研1类创新药11项，2项处于I期临床阶段，4项处于II期临床阶段，1项处于上市许可申请阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0096","BK1191","BK0097","BK0239","BK4585","BK1606","BK4588","BK1521","BK0175","BK0188","BK1197","KCAI","00874","BK0196","600332","BK0028","BK0012","VXUS","BK1515","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217677","title":"半年盘点｜研发费用增加致业绩承压，白云山想用短期阵痛换转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217677","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661217677?lang=zh_cn&edition=full","pubTime":"2026-08-23 11:47","pubTimestamp":1787456841,"startTime":"0","endTime":"0","summary":"对比一季报，白云山（600332.SH、00874.HK）近日公布的半年报业绩降幅有所扩大。根据半年报，今年上半年，白云山实现营业收入420.91亿元，同比增长0.61%；归属于上市公司股东的净利润20.96亿元，同比下降16.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608233850255226.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608233850255226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1191","BK1515","BK0175","BK0028","BK0012","00874","BK1606","BK0183","BK1521","BK0188","BK0070","BK0097","BK1197","600332","BK0096","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.111},{"period":"3month","weight":-0.0753},{"period":"6month","weight":-0.2372},{"period":"1year","weight":-0.226},{"period":"ytd","weight":-0.1985}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009908},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058543},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049537},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081866},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044368},{"month":6,"riseRate":0.482759,"avgChangeRate":0.018954},{"month":7,"riseRate":0.448276,"avgChangeRate":-0.011349},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.040031},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.010751},{"month":10,"riseRate":0.428571,"avgChangeRate":0.004089},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008393},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023642}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}